Not logged inA phase II study of pembrolizumab plus chemotherapy with short-course radiotherapy as induction treatment for unresectable locally advanced esophageal squamous cell carcinoma: PALADIN trial
Okemoto, D.; Kotani, D.; Nakamura, M.; Sato, K.; Kubo, Y.; Kadota, T.; Mishima, S.; Sakashita, S.; Hashimoto, T.; Bando, H.; Wakabayashi, M.; Rabinowitz, M.; Liu, M. C.; Jurdi, A.; Yamaguchi, T.; Nishikawa, H.; Shitara, K.; Yano, T.; Kojima, T.; Fujita, Takeo .png)
Share.png)
SaveReadministration of nivolumab for patients with advanced gastric cancer: a case seriesKodama, H.; Narita, Y.; Honda, K.; Masuishi, T.; Taniguchi, H.; Kadowaki, S.; Ando, M.; Tajika, M.; Yamaguchi, T.; Nishikawa, H.; Muro, K. Share Save Impact of claudin 18.2 expression on the efficacy of trastuzumab deruxtecan in patients with HER2-positive gastric or gastroesophageal junction cancerOkemoto, D.; Nakayama, I.; Jubashi, A.; Sakamoto, N.; Okunaka, M.; Matsubara, V.; Miyashita, V.; Kobayashi, A.; Okazaki, U.; Vamamoto, K.; Seguchi, K.; Hosokai, T.; Ogura, T.; Mishima, S.; Kotani, D.; Kawazoe, A.; Hashimoto, T.; Kuboki, V.; Bando, H.; Kojima, T.; Voshino, T.; Kuwata, T.; Vamaguchi, T.; Nishikawa, H.; Shitara, K. Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
